τwo-panel molecular testing for genetic predisposition for thrombosis using multi-allele visual biosensors

Analytical and Bioanalytical Chemistry

Volumn 408, Issue 7, 2016, Pages 1943-1952

  Fountoglou, Nikolaos ^a   Petropoulou, Margarita ^a   Iliadi, Alexandra ^a   Christopoulos, Theodore K ^b,c   Ioannou, Penelope C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

Author keywords

Molecular testing; Multi allele DNA biosensor; Primer extension reaction; Thrombophilia

Indexed keywords

BIOSENSORS; DISEASES; DNA; DNA SEQUENCES; ENZYME INHIBITION; GOLD NANOPARTICLES; POLYMERASE CHAIN REACTION;

DNA BIOSENSORS; GENETIC PREDISPOSITION; METHYLENETETRAHYDROFOLATE REDUCTASE; PLASMINOGEN ACTIVATOR INHIBITOR; PRIMER EXTENSION; STABILIZING FACTORS; THROMBOPHILIA; THROMBOTIC DISORDERS;

GENES;

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ALLELE; DNA MUTATIONAL ANALYSIS; EVALUATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC PROCEDURES; GENETICS; GENOTYPING TECHNIQUE; HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PROCEDURES; THROMBOSIS;

ALLELES; BIOSENSING TECHNIQUES; DNA; DNA MUTATIONAL ANALYSIS; FACTOR V; FACTOR XIII; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PLASMINOGEN ACTIVATOR INHIBITOR 1; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTHROMBIN; THROMBOSIS;

EID: 84961631743     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-016-9310-9     Document Type: Article

References (25)

1. Dahlbäck B. Blood. 2008;112:19–27.
2. Bertina RM. Clin Chem. 1997;43:1678–83.
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. Blood. 1996;88:3698–703.
4. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. Nat Genet. 1995;10:111–3.
5. Schwahn B, Rozen R. Am J Pharm. 2001;1:189–201.
6. Otrock ZK, Taher AT, Shamseddeen WA, Zaatari G, Bazarbachi A, Mahfouz RA. Ann Hematol. 2008;87:1013–6.
7. van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. Am J Hum Genet. 1998;62:1044–51.
8. Hanson NQ, Aras O, Yang F, Tsai MY. Clin Chem. 2001;47:661–6.
9. Ariens RAS, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Blood. 2002;100:743–54.
10. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, et al. Metabolism. 2000;49:845–52.
11. Torabi R, Zarei S, Zeraati H, Zarnani AH, Akhondi MM, Hadavi R, et al. J Reprod Infertil. 2012;13:89–94.
12. Gaudet M, Fara A, Beritognolo I, Maurizio Sabatti M. Methods Mol Biol. 2009;578:415–24.
13. Bagheri M, Rad I. Maedica. 2011;6:3–9.
14. Bortolin S. Methods Mol Biol. 2009;496:59–72.
15. Gabriel S, Ziaugra L, Tabbaa D. Curr Protoc Hum Genet 2.12.1-2.12.18. 2009.
16. De Stefano V, Rossi E, Paciaroni K, Leone G. Haematologica. 2002;87:1095–108.
17. Elenis DS, Ioannou PC, Christopoulos TK. Nanotechnology. 2011;22:155501.
18. Vlachou MA, Glynou KM, Ioannou PC, Christopoulos TK, Vartholomatos G. Biosens Bioelectron. 2010;26:228–34.
19. Toubanaki DK, Christopoulos TK, Ioannou PC, Gravanis A. Hum Mutat. 2008;29:1071–8.
20. Deeparani T, Radhakrishna PM, Elavazhagan T. Middle-East J Sci Res. 2009;2:127–32.
21. Kalogianni DP, Goura S, Aletras AJ, Christopoulos TK, Chanos MG, Christofidou M, et al. Anal Biochem. 2007;361:169–75.
22. Deng J, Pei J, Gou H, Ye Z, Liu C, Chen J. J Virol Methods. 2015;213:98–105.
23. Ang GY, Yu CY, Chan KG, Singh KK, Chan Yean Y. J Microbiol Methods. 2015;118:99–105.
24. Xu Y, Liu Y, Wu Y, Xia X, Liao Y, Li Q. Anal Chem. 2014;86:5611–4.
25. Litos IK, Ioannou PC, Christopoulos TK, Traeger-Synodinos J, Kanavakis E. Biosens Bioelectron. 2009;24:3135–9.